名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
NeuroSense Therapeutics Ltd | NRSNW | NASDAQ | Equity Warrant |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/6/18 | 06:25 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/6/18 | 06:24 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/6/18 | 06:22 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/5/28 | 20:14 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/5/24 | 05:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/5/23 | 13:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2024/5/23 | 06:00 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
2024/5/21 | 05:16 | EDGAR2 | Form F-1/A - Registration statement for certain foreign.. |
2024/5/20 | 22:02 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/5/14 | 22:02 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2024/5/11 | 05:15 | EDGAR2 | Form F-1 - Registration statement for certain foreign.. |
2024/5/07 | 23:21 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |